PM Wong's National Day Rally to begin at 6.45pm on Aug 17
He will speak first in Malay, followed by Mandarin. He will then deliver his speech in English at 8pm.
PM Wong will deliver his speech at ITE College Central in Ang Mo Kio.
It will also be broadcast on local TV channels and radio stations, and streamed live on PM Wong's and the Prime Minister's Office's YouTube channels.
The Straits Times will also cover the event live.
Those who miss the live broadcast can watch him delivering the speech on www.youtube.com/pmosingapore or www.pmo.gov.sg from Aug 18.
At his first National Day Rally in 2024, PM Wong spoke first in Malay, then in Mandarin and English.
During his maiden rally, he announced a slew of initiatives such as expanded parental leave, a SkillsFuture Jobseeker Support scheme to provide temporary financial support to those who have lost their jobs, and housing enhancements for couples, singles and seniors.
He also unveiled the Kallang Alive Masterplan, as well as a remake of Singapore's southern coast, with a continuous 120km-long waterfront stretching from Pasir Panjang Terminal to Tanah Merah Ferry Terminal.
Watch it live
Catch the speech on the ST website and ST's YouTube page.
Get alerts on your phone
Download the ST app and turn on notifications to receive news alerts.
In case you miss it
Catch up on all you need to know with a National Day Rally edition of the ST Evening Updates newsletter. Sign up now here.
Track what's trending
What topics stood out at the rally? Join the conversation on ST's social media channels and watch key moments in videos.
Source: The Straits Times © SPH Media Limited. Permission required for reproduction
Discover how to enjoy other premium articles here
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Compounding Pharmacy Market and Pharma Manufacturing Poised for Strong, Parallel Growth by 2030
HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Mordor Intelligence recently released comprehensive reports on compounding pharmacy market and pharma manufacturing industry, detailing robust growth trajectories for both sectors. Driven by increasing demand for personalized therapies and advanced production technologies, these markets are set to expand significantly through 2030, creating strategic opportunities for stakeholders across the healthcare value chain. Compounding Pharmacy Market Outlook The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says Mordor Intelligence. Growth stems from rising demand for customized medications, chronic pain management alternatives, and expanded bio-identical hormone therapies. Personalized formulations for pediatric and geriatric patients further bolster market uptake, ensuring precise dosing and improved adherence. "Our analysis indicates that the compounding sector is becoming a vital component of modern therapeutics," according to the Mordor Intelligence report on compounding pharmacies. "Continued API localization and advanced sterile workflows are key to meeting growing volumes while maintaining rigorous quality standards." For more details on the compounding pharmacy market report, visit: Key Drivers Behind Compounding Pharmacy Growth Personalized Medication Demand: Tailored pain-management mixes and hormone therapies address individual patient needs. Regulatory Frameworks: Guidelines permitting compounding during commercial drug shortages enhance market resilience. Technological Integration: Automated sterile systems and digital quality assurance streamline high-volume operations. Pharmaceutical Manufacturing Market Dynamics According to Mordor Intelligence, the pharmaceutical manufacturing market stands at roughly USD 506 billion in 2025 and is expected to ascend to approximately USD 811 billion by 2030, exhibiting a CAGR of 9.9%. Growth is anchored by reshoring incentives, continuous manufacturing adoption, and expansion of biosimilar capacity. Investment in AI-driven quality-control systems and modular plant designs accelerates time-to-market and supports diversified supply chains. "Advanced production technologies and regulatory support for continuous processes are transforming manufacturing economics," as per Mordor Intelligence's pharma manufacturing research report. "These trends enable manufacturers to balance scale with flexibility, essential for both blockbuster and niche therapies." For more details on the pharmaceutical manufacturing market report, visit: Emerging Trends in Pharmaceutical Manufacturing Continuous Processing Adoption: Cutting facility footprints and operating costs, supported by clear regulatory pathways. Biosimilar Surge: Patent expirations drive contract development and manufacturing organization (CDMO) engagement. Digital Integration: AI, IoT, and automation improve throughput, predictive maintenance, and batch-release timelines. Synergies and Market Implications Together, the rapid expansion of compounding pharmacies and the modernization of pharmaceutical manufacturing underscore a broader shift toward personalized, efficient, and resilient healthcare supply chains. Stakeholders—from CXOs and business analysts to healthcare research institutes—should monitor these intersecting markets for strategic partnerships, investment opportunities, and supply-chain optimizations. As these markets evolve, organizations equipped with actionable intelligence can capitalize on specialized formulations and advanced manufacturing capabilities. Mordor Intelligence's dual insights drive informed decision-making, empowering clients to navigate complexity and achieve sustainable growth in an increasingly competitive landscape. Explore more reports on the healthcare industry at Related Reports: Animal Drug Compounding Market: The market is projected to grow from USD 1.43 billion in 2025 to USD 2.04 billion by 2030 at a 7.4% CAGR. Growth is driven by personalized pet therapies, cannabinoid-based formulations, FDA-driven shortages, and AI-enabled compounding, while regulatory compliance and rising costs remain key Veterinary Drugs Market: The global market is projected to grow at a CAGR of 5.8%, driven by rising infectious diseases in pets and livestock, advancements in biologics, and increasing demand for animal-based products. The Lumpy Skin Disease (LSD) outbreak in Asia is accelerating vaccine R&D, with companies like Hester Biosciences developing vaccines to address this need. Such disease outbreaks and innovation efforts are expected to fuel market growth during the forecast OTC Drugs Market: The market is projected to grow from USD 195.96 billion in 2025 to USD 247.74 billion by 2030 at a 4.8% CAGR. Growth is driven by rising self-care trends, regulatory shifts enabling prescription-to-OTC switches, and demand for convenient formats like gummies and patches. Companies are adopting digital self-selection tools, track-and-trace technology, and omnichannel retail models to enhance trust and accessibility, especially in regions with high counterfeit risk. About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries, please contact:media@ 617-765-2493 Logo: View original content to download multimedia: SOURCE Mordor Intelligence Private Limited Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
6 minutes ago
- Yahoo
Lithium stocks soar after world's largest EV battery maker shutters mine in China
Lithium stocks soared early Monday after the world's largest EV battery maker closed its lithium mine in China, sending lithium prices soaring. The spike in lithium companies' stocks comes after Contemporary Amperex Technology (C7A0.F) announced early Monday morning that it was halting operations at one of its most important mines in China — also one of the world's largest — after its permit for the mine expired. The company said the Jianxiawo mine, the largest in China's Yichun lithium hub, will be shuttered for three months while it seeks to renew its license, according to Bloomberg. CATL is the largest EV battery manufacturer in the world, holding more than a third of the market. Shares of Albemarle (ALB) and Sociedad Química y Minera (SQM), the two largest lithium producers in the world, were up more than 11% and 9%, respectively, in early trading. Fellow major lithium miners and processors Lithium Americas (LAC) and Sigma Lithium (SGML) were up over 8% and 16%, respectively. The price of spot lithium was up nearly 4% on Monday; lithium prices have risen over 15% in the past month. Elon Musk's Tesla (TSLA) is one of CATL's biggest customers, according to a report from the Shanghai Metals Market. Tesla stock was up 2% early Monday morning. In January, the US Department of Defense added CATL to a list of companies it says are affiliated with the Chinese military. This would ban the Defense Department from signing procurement contracts with the company beginning in June 2026 CATL's move to shutter its mine will likely be seen as reflective of Beijing's increasing crackdown on "involution," which it sees as a phenomenon where increasing competitive prices for resources like lithium are self-defeating and end up slowing development instead of spurring it, according to the Financial Times. Lithium's centrality to the global market has exploded over the past few years due to the metal's key role in electric vehicles, storage capacity on power grids, and a variety of electronics, including phones and laptops. Demand for the metal could grow by as much as 40% by 2040, according to a forecast from the International Energy Agency. Lithium prices had fallen sharply over the past couple of years, hitting their lowest level since 2021 in June after dropping 20% from the start of the year, as mines around the world have continued to produce the rare-earth metal even as output has outpaced demand. Production in China alone has risen by 55% since 2023, according to data from commodities pricing agency Fastmarkets. "At this time, we see limited upside in the short term with a lack of pricing and market dynamics change, but also limited downside as we believe the market has bottomed out," UBS analysts wrote in a July research note. "This leaves investors in a 'no man's land', where trading and taking positions into equities is challenging." Jake Conley is a breaking news reporter covering US equities for Yahoo Finance. Follow him on X at @byjakeconley or email him at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Wall Street Journal
6 minutes ago
- Wall Street Journal
TNB Tech Minute: Nvidia, AMD to Give U.S. a Cut of AI Chip Sales to China - Tech News Briefing
Full Transcript This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Julie Chang: Here's your morning TNB Tech Minute for Monday, August 11th. I'm Julie Chang for the Wall Street Journal. Nvidia and Advanced Micro Devices will give the Trump administration a portion of their artificial intelligence chip sales to China. According to people familiar with the matter, the administration will receive 15% of sales revenue as part of a deal to approve exports of Nvidia's H20 AI chip to China. Sources say the same agreement was reached with AMD for one of its chips. The agreement isn't typical and it came after Nvidia CEO Jensen Huang met with President Trump last Wednesday when Trump said, "Tech companies that invest in the US would be exempt from new chip tariffs." Meanwhile, Intel CEO Lip-Bu Tan, is set to visit the White House today after Trump called for his removal last week over his ties to Chinese businesses. That's according to people familiar with the matter. Tan is expected to have a wide-ranging conversation with Trump with the intent of explaining his personal and professional background. Sources say Tan hopes to win Trump's approval by showing his commitment to the country and pledging the importance of keeping Intel's manufacturing capabilities as a national security issue. And shares of video-sharing site Rumble climbed after the company reported its second quarter results and said it intends to make an all-stock bid to buy AI cloud computing group Northern Data for about $1.17 billion. Rumble stock was up 18% in early morning trading. Through Friday's close, its shares had lost nearly 40% of their value since the start of the year. That's your TNB Tech Minute. Join us again this afternoon for more.
